Mirxes is a Singapore-headquartered molecular diagnostic company with R&D, manufacturing, and clinical lab operations in Singapore, USA, Japan, and China. We specialize in microRNA technologies and the development, manufacturing, and provision of diagnostic test kits and clinical services. Our mission is to enable early disease detection and provide insights for better patient care by harnessing the power of microRNA to augment traditional testing. Our vision is to be the world’s leading developer and provider of accurate, actionable, and affordable microRNA-powered diagnostic tests.

The Singapore Global Executive Programme (SGEP) is an exclusive talent development programme developed by Enterprise Singapore in partnership with high-growth local companies that possess global ambitions to build a strong pipeline of young talent within their organisations.

Talent will get the chance to hone industry expertise in a structured way, while equipping the...